CLINICAL-TRIALS AND STATISTICAL RIGOR - ARE THE BENEFITS NECESSARILY WORTH THE COST

被引:6
作者
SILVERBLATT, FJ
机构
关键词
D O I
10.1093/infdis/155.2.168
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:168 / 169
页数:2
相关论文
共 6 条
[1]   USING ECONOMIC-ANALYSIS TO DETERMINE THE RESOURCE CONSEQUENCES OF CHOICES MADE IN PLANNING CLINICAL-TRIALS [J].
DETSKY, AS .
JOURNAL OF CHRONIC DISEASES, 1985, 38 (09) :753-765
[2]   WHEN WAS A NEGATIVE CLINICAL-TRIAL BIG ENOUGH - HOW MANY PATIENTS YOU NEEDED DEPENDS ON WHAT YOU FOUND [J].
DETSKY, AS ;
SACKETT, DL .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (04) :709-712
[3]  
FIHN SD, 1985, REV INFECT DIS, V7, P468
[4]  
FRIEMAN JA, 1978, NEW ENGL J MED, V299, P690
[5]  
MAKUCH RW, 1986, ARCH INTERN MED, V146, P968
[6]  
1987, J INFECT DIS, V155, P170